| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |